Biogen International GmbH

Swiss Biotech Association

Member
Claim / update listing

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

http://www.biogen-international.com

Location

Neuhofstrasse 30, 6340 Baar, Switzerland

Facts & figures

Type of organization

Public company
Number of employees in Switzerland

>250

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
Mendrisio

Labatec Pharma SA

Labatec is a privately owned Swiss-based pharmaceutical company with more than 50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.
Meyrin

GlycoEra AG

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
8952 Schlieren